标题
The MYC oncogene — the grand orchestrator of cancer growth and immune evasion
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-09-10
DOI
10.1038/s41571-021-00549-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
- (2021) Sarah K. Madden et al. Molecular Cancer
- Capitalizing on Synthetic Lethality of MYC to Treat Cancer in the Digital Age
- (2021) Dexter Kai Hao Thng et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A mathematical model of tumor regression and recurrence after therapeutic oncogene inactivation
- (2021) Sharon S. Hori et al. Scientific Reports
- Target gene-independent functions of MYC oncoproteins
- (2020) Apoorva Baluapuri et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Myc instructs and maintains pancreatic adenocarcinoma phenotype
- (2020) Nicole M Sodir et al. Cancer Discovery
- MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity
- (2020) Renumathy Dhanasekaran et al. eLife
- Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
- (2020) Nathiya Muthalagu et al. Cancer Discovery
- Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells
- (2020) Manon Lernoux et al. Clinical Epigenetics
- Blocking Myc to Treat Cancer: Reflecting on Two Decades of Omomyc
- (2020) Daniel Massó-Vallés et al. Cells
- The Myc and Ras Partnership in Cancer: Indistinguishable Alliance or Contextual Relationship?
- (2020) Wadie Daniel Mahauad-Fernandez et al. CANCER RESEARCH
- A ligand-independent fast function of RARα promotes exit from metabolic quiescence upon T cell activation and controls T cell differentiation
- (2020) L. R. Friesen et al. Mucosal Immunology
- MYC functions as a switch for natural killer cell-mediated immune surveillance of lymphoid malignancies
- (2020) Srividya Swaminathan et al. Nature Communications
- MYC Antisense Oligonucleotide Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse models of Hepatocellular and Renal Cell Carcinoma
- (2020) Renumathy Dhanasekaran et al. Molecular Therapy-Nucleic Acids
- Translation control of the immune checkpoint in cancer and its therapeutic targeting
- (2019) Yichen Xu et al. NATURE MEDICINE
- Synergistic inhibition of pancreatic cancer with anti-PD-L1 and c-Myc inhibitor JQ1
- (2019) Yu Pan et al. OncoImmunology
- MYC Oncogene Contributions to Release of Cell Cycle Brakes
- (2019) Lucía García-Gutiérrez et al. Genes
- Long path to MYC inhibition approaches clinical trials
- (2019) M. Teresa Villanueva NATURE REVIEWS DRUG DISCOVERY
- Modelling the MYC-driven normal-to-tumour switch in breast cancer
- (2019) Corey Lourenco et al. Disease Models & Mechanisms
- Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
- (2019) Weiping Li et al. Journal of Hematology & Oncology
- Mission Possible: Advances in MYC Therapeutic Targeting in Cancer
- (2019) Brittany L. Allen-Petersen et al. BIODRUGS
- The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth
- (2019) Arvin M. Gouw et al. Cell Metabolism
- N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer
- (2019) Adeline Berger et al. JOURNAL OF CLINICAL INVESTIGATION
- Omomyc reveals new mechanisms to inhibit the MYC oncogene
- (2019) Mark J. Demma et al. MOLECULAR AND CELLULAR BIOLOGY
- Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy
- (2019) Huiying Han et al. CANCER CELL
- Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47
- (2019) Hiroaki Kamijo et al. LEUKEMIA
- Circular ecDNA promotes accessible chromatin and high oncogene expression
- (2019) Sihan Wu et al. NATURE
- MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer
- (2019) Marcel A. Dammert et al. Nature Communications
- CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma
- (2019) Shin Pai et al. Cells
- Convergence of Cancer Metabolism and Immunity: an Overview
- (2018) Chi Van Dang et al. Biomolecules & Therapeutics
- The MYC oncogene is a global regulator of the immune response
- (2018) Stephanie C. Casey et al. BLOOD
- Multiple DNA damage-dependent and DNA damage-independent stress responses define the outcome of ATR/Chk1 targeting in medulloblastoma cells
- (2018) Katharina Krüger et al. CANCER LETTERS
- Eya3 promotes breast tumor–associated immune suppression via threonine phosphatase–mediated PD-L1 upregulation
- (2018) Rebecca L. Vartuli et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex
- (2018) Ming-Hao Hu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex
- (2018) Debasish Dutta et al. NUCLEIC ACIDS RESEARCH
- PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells
- (2018) Otto Kauko et al. Science Translational Medicine
- The Expanding World of N-MYC–Driven Tumors
- (2018) David S. Rickman et al. Cancer Discovery
- Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy
- (2018) Soumaya Kouidhi et al. Frontiers in Immunology
- Myc and Ras, the Bonnie and Clyde of immune evasion
- (2018) Sílvia Casacuberta-Serra et al. Translational Cancer Research
- Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas
- (2018) Franz X. Schaub et al. Cell Systems
- The Translational Machinery of Human CD4+ T Cells Is Poised for Activation and Controls the Switch from Quiescence to Metabolic Remodeling
- (2018) Sara Ricciardi et al. Cell Metabolism
- FBXW7: a critical tumor suppressor of human cancers
- (2018) Chien-Hung Yeh et al. Molecular Cancer
- Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis
- (2018) Li Sun et al. Cell Death & Disease
- The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis
- (2018) Patrick A. Carroll et al. Frontiers of Medicine
- Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches
- (2018) Lavinia Carabet et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PIN1 in Cell Cycle Control and Cancer
- (2018) Chi-Wai Cheng et al. Frontiers in Pharmacology
- Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma
- (2018) Ian Lai et al. Journal for ImmunoTherapy of Cancer
- Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
- (2017) Matthew A. Coelho et al. IMMUNITY
- Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes
- (2017) Katrina E. Allison et al. IMMUNOLOGY
- CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2
- (2017) Liying Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma
- (2017) V Atsaves et al. LEUKEMIA
- Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity
- (2017) Kristen M. Turner et al. NATURE
- Inhibiting MYC binding to the E-box DNA motif by ME47 decreases tumour xenograft growth
- (2017) L C Lustig et al. ONCOGENE
- MYC: Master Regulator of Immune Privilege
- (2017) Stephanie C. Casey et al. TRENDS IN IMMUNOLOGY
- MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance
- (2017) Amy S. Farrell et al. Nature Communications
- Target guided synthesis using DNA nano-templates for selectively assembling a G-quadruplex binding c-MYC inhibitor
- (2017) Deepanjan Panda et al. Nature Communications
- MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma
- (2017) Sean T. Bailey et al. Nature Communications
- Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)
- (2017) Renumathy Dhanasekaran et al. Oncotarget
- Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis
- (2017) Jingwei Cheng et al. PLoS Pathogens
- MNT and Emerging Concepts of MNT‐MYC Antagonism
- (2017) Guang Yang et al. Genes
- MYC Deregulation in Primary Human Cancers
- (2017) Manpreet Kalkat et al. Genes
- Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors
- (2017) Keiichi Ohshima et al. Scientific Reports
- Targeting MYC in cancer therapy: RNA processing offers new opportunities
- (2016) Cheryl M. Koh et al. BIOESSAYS
- HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC- Driven Medulloblastoma
- (2016) Yanxin Pei et al. CANCER CELL
- A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers
- (2016) MoonSun Jung et al. CANCER RESEARCH
- Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
- (2016) Kimberly J. Briggs et al. CELL
- Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial
- (2016) J Edelmann et al. LEUKEMIA
- Fbxw7 Tumor Suppressor
- (2016) Jun Cao et al. MEDICINE
- Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival
- (2016) Daibiao Xiao et al. MOLECULAR CELL
- Metabolic maintenance of cell asymmetry following division in activated T lymphocytes
- (2016) Katherine C. Verbist et al. NATURE
- OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors
- (2016) L A Jung et al. ONCOGENE
- PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
- (2016) Kanak Raina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression
- (2015) Kenneth M. Felsenstein et al. ACS Chemical Biology
- Functional Genomics Analysis Reveals a MYC Signature Associated with a Poor Clinical Prognosis in Liposarcomas
- (2015) Dat Tran et al. AMERICAN JOURNAL OF PATHOLOGY
- Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis
- (2015) Daniel Diolaiti et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Small-molecule inhibitors of the Myc oncoprotein
- (2015) Steven Fletcher et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Myc and cell cycle control
- (2015) Gabriel Bretones et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies
- (2015) C. M. Adams et al. CANCER RESEARCH
- Reduced Expression of MYC Increases Longevity and Enhances Healthspan
- (2015) Jeffrey W. Hofmann et al. CELL
- Oncogenic Myc Induces Expression of Glutamine Synthetase through Promoter Demethylation
- (2015) Alex J. Bott et al. Cell Metabolism
- Catalytic in vivo protein knockdown by small-molecule PROTACs
- (2015) Daniel P Bondeson et al. Nature Chemical Biology
- Spatial genomic heterogeneity within localized, multifocal prostate cancer
- (2015) Paul C Boutros et al. NATURE GENETICS
- MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism
- (2015) Emelyn H. Shroff et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phthalimide conjugation as a strategy for in vivo target protein degradation
- (2015) G. E. Winter et al. SCIENCE
- Targeting Translation Initiation Bypasses Signaling Crosstalk Mechanisms That Maintain High MYC Levels in Colorectal Cancer
- (2015) A. Wiegering et al. Cancer Discovery
- MYC, Metabolism, and Cancer
- (2015) Z. E. Stine et al. Cancer Discovery
- c-Myc Suppression of DNA Double-strand Break Repair
- (2015) Zhaozhong Li et al. NEOPLASIA
- MYC through miR-17-92 Suppresses Specific Target Genes to Maintain Survival, Autonomous Proliferation, and a Neoplastic State
- (2014) Yulin Li et al. CANCER CELL
- Drugging MYCN through an Allosteric Transition in Aurora Kinase A
- (2014) William Clay Gustafson et al. CANCER CELL
- STAT1 Drives Tumor Progression in Serous Papillary Endometrial Cancer
- (2014) B. Kharma et al. CANCER RESEARCH
- CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
- (2014) Edmond Chipumuro et al. CELL
- Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53
- (2014) G. L. Kelly et al. GENES & DEVELOPMENT
- Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
- (2014) Nicholas Kwiatkowski et al. NATURE
- Alteration of the lipid profile in lymphomas induced by MYC overexpression
- (2014) L. S. Eberlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- c-MYC-Induced Genomic Instability
- (2014) A. Kuzyk et al. Cold Spring Harbor Perspectives in Medicine
- Therapeutic Strategies to Inhibit MYC
- (2014) M. R. McKeown et al. Cold Spring Harbor Perspectives in Medicine
- MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
- (2014) M. Gabay et al. Cold Spring Harbor Perspectives in Medicine
- An Overview of MYC and Its Interactome
- (2014) M. Conacci-Sorrell et al. Cold Spring Harbor Perspectives in Medicine
- Oncogene withdrawal engages the immune system to induce sustained cancer regression
- (2014) Stephanie C Casey et al. Journal for ImmunoTherapy of Cancer
- Regulation of c-Myc Ubiquitination Controls Chronic Myelogenous Leukemia Initiation and Progression
- (2013) Linsey Reavie et al. CANCER CELL
- The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability
- (2013) Bryan King et al. CELL
- Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice
- (2013) L. Soucek et al. GENES & DEVELOPMENT
- Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity
- (2013) X Zhao et al. LEUKEMIA
- Pin1 Regulates the Dynamics of c-Myc DNA Binding To Facilitate Target Gene Regulation and Oncogenesis
- (2013) A. S. Farrell et al. MOLECULAR AND CELLULAR BIOLOGY
- Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes
- (2013) Jehan J. El-Jawhari et al. MOLECULAR IMMUNOLOGY
- Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers
- (2013) M. Pourdehnad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Thrombospondin-1 Signaling through CD47 Inhibits Self-renewal by Regulating c-Myc and Other Stem Cell Transcription Factors
- (2013) Sukhbir Kaur et al. Scientific Reports
- Roles for MYC in the Establishment and Maintenance of Pluripotency
- (2013) J. Chappell et al. Cold Spring Harbor Perspectives in Medicine
- MYC, Metabolism, Cell Growth, and Tumorigenesis
- (2013) C. V. Dang Cold Spring Harbor Perspectives in Medicine
- MAX and MYC: A Heritable Breakup
- (2012) A. Cascon et al. CANCER RESEARCH
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
- (2012) Anne Le et al. Cell Metabolism
- Patent watch
- (2012) Charlotte Harrison NATURE REVIEWS DRUG DISCOVERY
- Metabolic pathways in T cell fate and function
- (2012) Valerie A. Gerriets et al. TRENDS IN IMMUNOLOGY
- Combining Histone Deacetylase Inhibitor Vorinostat with Aurora Kinase Inhibitors Enhances Lymphoma Cell Killing with Repression of c-Myc, hTERT, and microRNA Levels
- (2011) L. Kretzner et al. CANCER RESEARCH
- Phosphorylation Regulates c-Myc's Oncogenic Activity in the Mammary Gland
- (2011) X. Wang et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in wilms tumor
- (2011) Richard D. Williams et al. GENES CHROMOSOMES & CANCER
- Demonstration that Drug-targeted Down-regulation of MYC in Non-Hodgkins Lymphoma Is Directly Mediated through the Promoter G-quadruplex
- (2011) Robert V. Brown et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors
- (2011) Matilde Murga et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis
- (2011) J. D. Kessler et al. SCIENCE
- Survival and Death Signals Can Predict Tumor Response to Therapy After Oncogene Inactivation
- (2011) P. T. Tran et al. Science Translational Medicine
- Tumor Stroma-Derived TGF-β Limits Myc-Driven Lymphomagenesis via Suv39h1-Dependent Senescence
- (2010) Maurice Reimann et al. CANCER CELL
- CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation
- (2010) Kavya Rakhra et al. CANCER CELL
- Silencing of Thrombospondin-1 Is Critical for Myc-Induced Metastatic Phenotypes in Medulloblastoma
- (2010) L. Zhou et al. CANCER RESEARCH
- The Myc-miR-17 92 Axis Blunts TGF Signaling and Production of Multiple TGF -Dependent Antiangiogenic Factors
- (2010) M. Dews et al. CANCER RESEARCH
- The interaction between Myc and Miz1 is required to antagonize TGF -dependent autocrine signaling during lymphoma formation and maintenance
- (2010) J. van Riggelen et al. GENES & DEVELOPMENT
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase
- (2010) D. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic and Proteomic Analysis Reveals a Threshold Level of MYC Required for Tumor Maintenance
- (2008) C. M. Shachaf et al. CANCER RESEARCH
- Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
- (2008) Bora Gurel et al. MODERN PATHOLOGY
- Combined Inactivation of MYC and K-Ras Oncogenes Reverses Tumorigenesis in Lung Adenocarcinomas and Lymphomas
- (2008) Phuoc T. Tran et al. PLoS One
- Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
- (2008) D. R. Wise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma
- (2008) E. Fredlund et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More